- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.95 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x 6MD: N-methyladenosine(Non-covalent)
- 24 x GOL: GLYCEROL(Non-functional Binders)
GOL.2: 5 residues within 4Å:- Chain A: G.177, T.178, A.179
- Ligands: 6MD.1, GOL.5
Ligand excluded by PLIPGOL.3: 8 residues within 4Å:- Chain A: L.130, M.133, S.134, A.137, L.240, I.267, P.302
- Ligands: SO4.8
Ligand excluded by PLIPGOL.4: 8 residues within 4Å:- Chain A: A.116, T.119, K.341, G.342, L.343, S.344, S.352, V.355
Ligand excluded by PLIPGOL.5: 6 residues within 4Å:- Chain A: A.126, L.127, A.131, S.134, T.178
- Ligands: GOL.2
Ligand excluded by PLIPGOL.10: 5 residues within 4Å:- Chain B: G.177, T.178, A.179
- Ligands: 6MD.9, GOL.13
Ligand excluded by PLIPGOL.11: 8 residues within 4Å:- Chain B: L.130, M.133, S.134, A.137, L.240, I.267, P.302
- Ligands: SO4.16
Ligand excluded by PLIPGOL.12: 8 residues within 4Å:- Chain B: A.116, T.119, K.341, G.342, L.343, S.344, S.352, V.355
Ligand excluded by PLIPGOL.13: 6 residues within 4Å:- Chain B: A.126, L.127, A.131, S.134, T.178
- Ligands: GOL.10
Ligand excluded by PLIPGOL.18: 5 residues within 4Å:- Chain C: G.177, T.178, A.179
- Ligands: 6MD.17, GOL.21
Ligand excluded by PLIPGOL.19: 8 residues within 4Å:- Chain C: L.130, M.133, S.134, A.137, L.240, I.267, P.302
- Ligands: SO4.24
Ligand excluded by PLIPGOL.20: 8 residues within 4Å:- Chain C: A.116, T.119, K.341, G.342, L.343, S.344, S.352, V.355
Ligand excluded by PLIPGOL.21: 6 residues within 4Å:- Chain C: A.126, L.127, A.131, S.134, T.178
- Ligands: GOL.18
Ligand excluded by PLIPGOL.26: 5 residues within 4Å:- Chain D: G.177, T.178, A.179
- Ligands: 6MD.25, GOL.29
Ligand excluded by PLIPGOL.27: 8 residues within 4Å:- Chain D: L.130, M.133, S.134, A.137, L.240, I.267, P.302
- Ligands: SO4.32
Ligand excluded by PLIPGOL.28: 8 residues within 4Å:- Chain D: A.116, T.119, K.341, G.342, L.343, S.344, S.352, V.355
Ligand excluded by PLIPGOL.29: 6 residues within 4Å:- Chain D: A.126, L.127, A.131, S.134, T.178
- Ligands: GOL.26
Ligand excluded by PLIPGOL.34: 5 residues within 4Å:- Chain E: G.177, T.178, A.179
- Ligands: 6MD.33, GOL.37
Ligand excluded by PLIPGOL.35: 8 residues within 4Å:- Chain E: L.130, M.133, S.134, A.137, L.240, I.267, P.302
- Ligands: SO4.40
Ligand excluded by PLIPGOL.36: 8 residues within 4Å:- Chain E: A.116, T.119, K.341, G.342, L.343, S.344, S.352, V.355
Ligand excluded by PLIPGOL.37: 6 residues within 4Å:- Chain E: A.126, L.127, A.131, S.134, T.178
- Ligands: GOL.34
Ligand excluded by PLIPGOL.42: 5 residues within 4Å:- Chain F: G.177, T.178, A.179
- Ligands: 6MD.41, GOL.45
Ligand excluded by PLIPGOL.43: 8 residues within 4Å:- Chain F: L.130, M.133, S.134, A.137, L.240, I.267, P.302
- Ligands: SO4.48
Ligand excluded by PLIPGOL.44: 8 residues within 4Å:- Chain F: A.116, T.119, K.341, G.342, L.343, S.344, S.352, V.355
Ligand excluded by PLIPGOL.45: 6 residues within 4Å:- Chain F: A.126, L.127, A.131, S.134, T.178
- Ligands: GOL.42
Ligand excluded by PLIP- 18 x SO4: SULFATE ION(Non-functional Binders)
SO4.6: 4 residues within 4Å:- Chain A: R.156, E.167, K.259
- Chain F: K.307
Ligand excluded by PLIPSO4.7: 4 residues within 4Å:- Chain A: V.58, G.59, T.60, Q.63
Ligand excluded by PLIPSO4.8: 6 residues within 4Å:- Chain A: R.15, K.75, M.133, N.300, P.302
- Ligands: GOL.3
Ligand excluded by PLIPSO4.14: 4 residues within 4Å:- Chain B: R.156, E.167, K.259
- Chain E: K.307
Ligand excluded by PLIPSO4.15: 4 residues within 4Å:- Chain B: V.58, G.59, T.60, Q.63
Ligand excluded by PLIPSO4.16: 6 residues within 4Å:- Chain B: R.15, K.75, M.133, N.300, P.302
- Ligands: GOL.11
Ligand excluded by PLIPSO4.22: 4 residues within 4Å:- Chain C: R.156, E.167, K.259
- Chain D: K.307
Ligand excluded by PLIPSO4.23: 4 residues within 4Å:- Chain C: V.58, G.59, T.60, Q.63
Ligand excluded by PLIPSO4.24: 6 residues within 4Å:- Chain C: R.15, K.75, M.133, N.300, P.302
- Ligands: GOL.19
Ligand excluded by PLIPSO4.30: 4 residues within 4Å:- Chain C: K.307
- Chain D: R.156, E.167, K.259
Ligand excluded by PLIPSO4.31: 4 residues within 4Å:- Chain D: V.58, G.59, T.60, Q.63
Ligand excluded by PLIPSO4.32: 6 residues within 4Å:- Chain D: R.15, K.75, M.133, N.300, P.302
- Ligands: GOL.27
Ligand excluded by PLIPSO4.38: 4 residues within 4Å:- Chain B: K.307
- Chain E: R.156, E.167, K.259
Ligand excluded by PLIPSO4.39: 4 residues within 4Å:- Chain E: V.58, G.59, T.60, Q.63
Ligand excluded by PLIPSO4.40: 6 residues within 4Å:- Chain E: R.15, K.75, M.133, N.300, P.302
- Ligands: GOL.35
Ligand excluded by PLIPSO4.46: 4 residues within 4Å:- Chain A: K.307
- Chain F: R.156, E.167, K.259
Ligand excluded by PLIPSO4.47: 4 residues within 4Å:- Chain F: V.58, G.59, T.60, Q.63
Ligand excluded by PLIPSO4.48: 6 residues within 4Å:- Chain F: R.15, K.75, M.133, N.300, P.302
- Ligands: GOL.43
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kim, H.-B. et al., Drug target analysis by dye-ligand affinity chromatography. To be Published
- Release Date
- 2013-11-06
- Peptides
- Alanine dehydrogenase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.95 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x 6MD: N-methyladenosine(Non-covalent)
- 24 x GOL: GLYCEROL(Non-functional Binders)
- 18 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kim, H.-B. et al., Drug target analysis by dye-ligand affinity chromatography. To be Published
- Release Date
- 2013-11-06
- Peptides
- Alanine dehydrogenase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A